Table 2.
Number of Records | L1swd, s | D1swd, s | L2, s | D2, s | D3, s | D2swd, s | ||
---|---|---|---|---|---|---|---|---|
Type 1 | 8 | Median Q1–Q3 |
160.5 102.3−316.8 |
330.0 146.3–590.5 |
514.0 262.3–854.3 |
1618.5 1255.0–3103.3 |
1005.0 252.0–1575.0 |
4990.0 3482.5–7146.8 |
Type 2 | 8 | Median Q1–Q3 |
188.0 168.3–225.5 |
9257.5 4557.0–12,220.5 |
- | - | - | - |
Abbreviations: L1swd—the latency of the first SWD after the injection; D1swd—the duration of the first period of enhanced spike-wave epileptic activity; L2—the latency of the sedative state; D2—the duration of sedative state; D3—the duration of the deep sedation phase; D2swd—the duration of the second period of enhanced spike-wave epileptic activity.